PPT-Effects of HIV/HCV coinfection on Bone Mineral Density and Structure

Amber Wheeler MD WIHS Scientific Meeting June 30 2014 Objectives To discuss Background Aims Preliminary rough data Future Directions HIVinfected persons have increased odds of . Marie-Louise Vachon, MD, . MSc. Division of . Infectious. . Diseases. Centre Hospitalier Universitaire de Québec. Management of HCV . in Co-Infected Patients. Prevention and counselling. Baseline laboratory testing. HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Trial. Phase . 3. Sulkowski. MS, et al. JAMA. 2014;312:353-61.. Treatment. Naïve and Treatment . Experienced. HIV Coinfection. Source: . Sulkowski. MS, et al. JAMA. 2014;312:353-61.. Cathryn. L. Samples, MD, MPH, AAHIVS. Director, Boston HAPPENS. Boston Children’s Hospital. Presented at: Improving . Care for Substance Use, HIV and HCV in Adolescents: . Effective Approaches to Assessing, Treating, and Engaging . Co-Infection – Florida, . 2014. . STD and Hepatitis Section in collaboration with HIV/AIDS Section – Surveillance Unit . Division of Disease Control and Health Protection. HIV Disease data from 1981 through December . Presented by: . Fabian Cretu, Beverly-Ann Oliver, Kristina Miclat, Maeryl Sumagang. PHM142. September 25, 2018. PHM142 Fall . 2018. Instructor: . Ms. Maya Latif. Coordinator: Dr. J. Henderson. HIV. Co-Infection – Florida, . 2014. . STD and Hepatitis Section in collaboration with HIV/AIDS Section – Surveillance Unit . Division of Disease Control and Health Protection. HIV Disease data from 1981 through December . . HCV . testing and treatment. Lorenzo McFarland, DHA, MPH, MSW, PMP. USAF/Ret E-7 - Senior Program Manager. HIV, Hepatitis, and Related Conditions Program. Office of Specialty Care Services. Deputy Under Secretary for Health for Policy and Planning. Go to: pollev.com/CCO2. or scan the QR code below. *All responses are anonymous and cannot be linked to individual participants.. Contemporary Management of HIV: Managing HIV in Viral Hepatitis Coinfection. Co-Infection – Florida, . 2013. . STD and Hepatitis Section in collaboration with HIV/AIDS Section – Surveillance Unit . Division of Disease Control and Health Protection. HIV Disease data from 1981 through December . Todd S. Wills, MD. Martha Friedrich, PhD. SPNS Hepatitis C Treatment Expansion Initiative. University of South Florida. The HIV/HCV Disease Burden. Hepatitis C. In U.S., 4 million HCV+ . →. 85% chronic . Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017. Available HCV treatment DAAs. Epclusa. (. sofosbuvir. / . velpatasvir. ). Harvoni. (. sofosbuvir. / . ledipasvir. ). Zepatier. (. grazoprevir. / . (Resolution 13). Ad Hoc Disease Transmission Advisory Committee (DTAC) Committee. November 12-13, 2014. June 2013- US Public Health Service released new PHS Guideline that now include Hepatitis B (HBV) and Hepatitis C (HCV) in addition to HIV. (mainly collagen. ). components. Treated with hydrochloric acid to dissolve mineral (. . Ca. 10. (PO. 4. ). 6. (OH). 2. . ). leaves collagen component intact. Collagen shrinkage on drying. Treated with bleach (hypochlorite) to digest collagen. Teri Griep-Langholz, RN, HIV/HCV Program Nurse Case Manager. Siouxland Community Health Center. Sioux City, IA . Beyond the Yellow Brick Road—Incorporating HCV into HIV Treatment Model. Learning Objectives.